Testicular cancer laboratory tests

Testicular cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Testicular cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Testicular cancer laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Testicular cancer laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Testicular cancer laboratory tests

CDC on Testicular cancer laboratory tests

Testicular cancer laboratory tests in the news

Blogs on Testicular cancer laboratory tests

Directions to Hospitals Treating Testicular cancer

Risk calculators and risk factors for Testicular cancer laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

## Overview

[edit | edit source]

An elevated concentration of blood tumor marker tests is diagnostic of testicular cancer.

## Laboratory Tests

[edit | edit source]

Tumor marker tests[1]

* Alpha-fetoprotein (AFP)
* Human chorionic gonadotropin (HCG)
* Lactate dehydrogenase (LDH)

## References

[edit | edit source]

1. ↑ Testicular cancer.2015 Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/testicular/diagnosis/?region=ab#CBC Accessed on October, 13 2015

Template:WikiDoc Sources